More Articles

SMi 10th Annual Biosimilars and Biologics Conference 2019 Conferences | Posted 17/05/2019

SMi 10th Annual Biosimilars and Biologics Conference 2019 25–26 September 2019 Copthorne Tara Hotel London, UK

Biosimilars education still needed for US and EU clinicians Biosimilars/Research | Posted 10/05/2019

A review of the literature has concluded that healthcare providers are still cautious when it comes to biosimilars and that clinician-directed education is still needed to increase biosimilar knowl...

EMA approval for pegfilgrastim biosimilar Grasustek Biosimilars/News | Posted 10/05/2019

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 26 April 2019 that it had recommended the granting of a marketing authorization for the pegf...

Automatic pharmacist substitution of biosimilars in Germany Policies & Legislation | Posted 10/05/2019

Pharmacists in Germany may soon be able to carry out automatic substitution of biosimilars in the country.

Patient and provider views on biosimilars to treat breast cancer Biosimilars/General | Posted 10/05/2019

A Canadian breast cancer advocacy group collected insights from patients and medical oncologists regarding the use of biosimilar treatments.

Challenges for biosimilar sustainability in Europe Reports | Posted 10/05/2019

At the 17th Biosimilar Medicines Conference, Executive Director of the IQVIA Institute for Human Data Science (formerly the IMS Institute), Murray Aitken, outlined the challenges facing biosimilars...

FDA pledges to improve quality of compounded drugs Guidelines | Posted 10/05/2019

The US Food and Drug Administration (FDA) released a statement on 3 April 2019 detailing its priorities for improving the quality of compounded drugs in 2019.

Pharmacokinetic assessment of biosimilar therapeutic monoclonal antibodies Biosimilars/Research | Posted 10/05/2019

Comparison of the clinical pharmacokinetic (PK) profile of a biosimilar with that of the reference product is an important step in the development of biosimilars. In a recent review, Ishii-Watabe a...